Filing Details
- Accession Number:
- 0000899243-16-023278
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2016-06-20 16:08:28
- Reporting Period:
- 2016-06-15
- Filing Date:
- 2016-06-20
- Accepted Time:
- 2016-06-20 16:08:28
- Original Submission Date:
- 2016-06-17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1042418 | Hedgepath Pharmaceuticals Inc. | HPPI | Services-Commercial Physical & Biological Research (8731) | 541641133 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1066040 | Jr E Francis Odonnell | 324 S. Hyde Park Avenue, Suite 350 Tampa FL 33606 | Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.0001 Par Value Per Share | Acquisiton | 2016-06-15 | 2,560,000 | $0.00 | 16,560,000 | No | 4 | P | Indirect | By Hopkins Capital Group II, LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Hopkins Capital Group II, LLC |
Footnotes
- On June 15, 2016, Hedgepath LLC transferred 2,560,000 shares of common stock to Hopkins Capital Group II, LLC ("HCGII") in satisfaction of $192,000 in then outstanding debt. This amendment to Form 4 is being filed by the Reporting Person to correctly reflect that the shares were transferred to HCGII and not transferred by HCGII to a third party.
- The shares are owned by HCGII. The Reporting Person is a discretionary beneficiary of an irrevocable spendthrift trust which directly owns a minority membership interest in HCGII. The Reporting Person disclaims ownership of all securities held by HCGII.